ORIGINAL RESEARCH
Accepted on 21 Apr 2025
Anticancer Activity of RM-3-22: A TAZQ-Based Hydroxamic Acid Derivative Targeting NSCLC In Vitro and In Vivo
doi 10.3389/fphar.2025.1544666
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Unlocking Autophagy’s Full Potential: Embracing a Multidimensional Approach for Targeted Cancer Treatment
Unlocking Autophagy’s Full Potential: Embracing a Multidimensional Approach for Targeted Cancer Treatment
1,041
Total downloads
4,524
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 09 Jan 2025
Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC
doi 10.3389/fonc.2024.1509183
- 545 views
- 1 citation
REVIEW
Published on 07 Jun 2024
To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics
doi 10.3389/fphar.2024.1419806
- 1,427 views
REVIEW
Published on 28 Feb 2024
The potential anti-tumor effect of anesthetics on cancer by regulating autophagy
doi 10.3389/fphar.2024.1293980
- 1,091 views
- 4 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: